About Ascent Pharma Private Limited
Data last updated:
Ascent Pharma Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24230BR2003PTC010329. Its GSTIN is 10AAECA9427G1Z0 (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Manju Sinha (Managing Director) and Manoj Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mahatma Gandhi Nagar Kanti Factory Road West To Kali Mandir Plot – 825, Patna, Bihar, India.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.04 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹21,630 (net margin 0.2%) and EBITDA of ₹2.6 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹41 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ascentpharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressMahatma Gandhi Nagar Kanti Factory Road West To Kali Mandir Plot – 825, Patna, Bihar, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ascent Pharma Private Limited
The main business activity of Ascent Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ascent Pharma Private Limited FY 2025 filings available
Ascent Pharma Private Limited reported revenue of ₹87.04 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ascent Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 19% growth in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ascent Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹21,630 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ascent Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ascent Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ascent Pharma Private Limited
Ascent Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Misha Biotech Private Limited | ₹87.14 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Chandigarh, India |
| Module Pharmaceutical Private Limited | ₹87.14 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Bangalore, Karnataka, India |
| Lividus Healthcare Private Limited | ₹87.13 Lakh (FY 2025) | •••• | •••• | 2692.0% | •••• | Karunagappally, Kerala, India |
| Nishant Distributors Private Limited | ₹87.06 Lakh (FY 2025) | •••• | •••• | -26.0% | •••• | Ranchi, Jharkhand, India |
| SVS Intermediates Private Limited | ₹87.05 Lakh (FY 2022) | •••• | •••• | -29.0% | •••• | Singavaram, Telangana, India |
| Ascent Pharma Private Limited this company | ₹87.04 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Patna, Bihar, India |
| Rosylyn Pharmaceuticals Private Limited | ₹86.97 Lakh (FY 2024) | •••• | •••• | 117.0% | •••• | Rewa, Madhya Pradesh, India |
| Vqure Pharmaceuticals Private Limited | ₹86.82 Lakh (FY 2023) | •••• | •••• | -36.0% | •••• | Thane, Maharashtra, India |
| Elemensis Lifesciences Private Limited | ₹86.75 Lakh (FY 2025) | •••• | •••• | 373.0% | •••• | Delhi, India |
| Prescription Medicines Pvt Ltd | ₹86.68 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Tenfold Pharmaceuticals Private Limited | ₹86.68 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Jaipur, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Ascent Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ascent Pharma Private Limited
Ascent Pharma Private Limited is audited by RAJESH THAKUR & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH THAKUR & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ascent Pharma Private Limited
Ascent Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Kumar | Director | 04 Sep 2003 | 23 Years 1 Months | Current |
| Manju Sinha | Managing Director | 04 Sep 2003 | 23 Years 1 Months | Current |
| Rohit Raj | Director | 05 Jul 2021 | 5 Years 3 Months | Current |
Ownership and Shareholding of Ascent Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ascent Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2022 | Others | ₹30 Lakh | Open |
| 03 Nov 2003 | Others | ₹11 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Ascent Pharma Private Limited
Ascent Pharma Private Limited has 1 court case on record: 1 filed by Ascent Pharma. All case is disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Patna, Bihar | Court case (Cr. Case Complaint (P)) | Filed by the company against an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Ascent Pharma Private Limited
Employment history and EPFO contributions of people linked to Ascent Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Ascent Pharma Private Limited
Ascent Pharma has one previous CIN (Corporate Identification Number): U00304BR2003PTC010329. The current CIN is U24230BR2003PTC010329, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230BR2003PTC010329 | Current |
| U00304BR2003PTC010329 | Previous |
Recent Activity on Ascent Pharma Private Limited
Ascent Pharma Private Limited has 3 board changes on record since 2003: 3 appointments. The latest: Rohit Raj was appointed as Director on 05 Jul 2021.
Credit Ratings, Litigation & Regulatory Alerts for Ascent Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ascent Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ascent Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ascent Pharma Private Limited
Ascent Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECA9427G1Z0 | Bihar | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ascent Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ascent Pharma Private Limited
Ascent Pharma is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2003 (23+ years old) and is registered under CIN U24230BR2003PTC010329.
Ascent Pharma reported revenue of ₹87.04 Lakh for FY 2025 (up 19% YoY).
Ascent Pharma has 3 current directors:
- Manju Sinha - Managing Director
- Manoj Kumar - Director
- Rohit Raj - Director
Ascent Pharma reported a net profit of ₹21,630 (net margin 0.2%) and EBITDA of ₹2.6 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ascent Pharma is 14% over three years and 12% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ascent Pharma is 10AAECA9427G1Z0, registered in Bihar.
The CIN (Corporate Identification Number) of Ascent Pharma is U24230BR2003PTC010329. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ascent Pharma has 1 court case on record: 1 filed by the company.
Ascent Pharma was incorporated on 04 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Ascent Pharma by revenue are Misha Biotech Private Limited, Module Pharmaceutical Private Limited, Lividus Healthcare Private Limited, Nishant Distributors Private Limited, SVS Intermediates Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Rohit Raj was appointed as Director on 05 Jul 2021. Manju Sinha was appointed as Managing Director on 04 Sep 2003. Manoj Kumar was appointed as Director on 04 Sep 2003.